Skip to main content
. 2019 Sep 27;39(4):849–861. doi: 10.1038/s41388-019-1027-8

Table 1.

Patient and tumor characteristics

WT01a WT02 WT03 WT04 WT05
Sex Female Male Male Female Male
Age (months) 23 33 42 50 10
Response to preoperative chemotherapy Good (80% volume reduction) Good (70% volume reduction) Good (70% volume reduction) Progress Progress
Tumor type Regressive (vital part: blastema) Triphasic Blastemal Epithelial, with diffuse anaplasia Stromal
Stage III II I I I (V)
Outcome/event free survival (EFS) >3.5 years EFS >1 year EFS >9 months EFS >4 years EFS Lung metastasis at 1 year, >3 years EFS
Histology of starting material Blastemal xenograft Blastemal with few stromal elements Blastemal with few stromal elements Epithelial Stromal lung metastasis

aReported as WT046 in [7]